About Aclaris (ACRS)
Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a physician-led, biopharmaceutical company focused on immuno-inflammatory diseases. The Company is focused on leveraging its experience in drug discovery and development and kinase inhibit... Read more
- USD1.20
- USD1.20
- USD1.16
- USD11.12
- 2.60%
- 31M
- 374.98k
- 755.36k
- 88M
- 0.59
- -86.70%
Stock News
2 hours ago
Foreign automakers eager for Chinese partners at Beijing auto show
Yahoo
3 hours ago
Bank of the James Announces First Quarter of 2024 Financial Results and Declaration of Dividend
Yahoo
3 hours ago
FAFSA delays could have some students thinking about a gap year—3 factors to consider before you do
CNBC
3 hours ago
China tech beating Apple? Happy GM, Dirac future – the week
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
